Hematology
Article
Immunotherapies shape the treatment landscape for hematologic malignancies
Outcomes Research in Review
Does Oral Chemotherapy Venetoclax Combined with Rituximab Improve Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia?
Outcomes Research in Review
CAR T-Cell Therapy Shows High Levels of Durable Response in Refractory Large B-Cell Lymphoma
News
Five-year survival for non-Hodgkin lymphoma tops 71%
The most advanced cases are the most likely to be diagnosed.
News
Coming soon: CAR T-cell approvals in multiple myeloma
CAR T-cell approvals for multiple myeloma are on the horizon and will transform oncology, according to Dr. Carl June.
FDA/CDC
Gene therapy for hemophilia A gets fast-track review
The FDA has granted breakthrough therapy designation to a gene therapy product aimed at hemophilia A.
Article
Hospitalizations for fracture in patients with metastatic disease: primary source lesions in the United States
News
The T-cell repertoire in NSCLC: Therapeutic implications
New findings regarding the T-cell repertoire in NSCLC patients could have implications for the use of TIL therapy, checkpoint blockade, and more...
News
Transparency lacking in oncology clinical pathways
Health plans are under fire for the hidden conflicts of interest in their clinical pathway panels.
